Delivery Order SPE2DB22D3501-SPE2DB25FWM11
Award Date 7/18/25
Potential Completion Date 7/21/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,728.48 on July 22, 2025, for the supply of Aranespâ„¢ 40 mcg/0.4 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in...
- This is a $2,542.80 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 40 mcg/0.4 mL syringes of the drug Aranesp, with a performance period through June 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,985.76 by the Defense Logistics Agency (DLA) on July 24, 2025. The contract calls for the delivery of Aranesp 25 micrograms/0.42 milliliter syringes, a medication used to treat anemia in patients with chronic kidney disease and cancer patients undergoing chemotherapy. This is a firm fixed-price delivery order with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $4,502.24 to AmerisourceBergen Drug Corp for Aranesp 40 mcg/0.4 mL syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a continuation of the company's role as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,880.65 firm fixed-price contract is to provide Aranesp 200 MCG/0.4 ML syringes. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,173.37 award is for the supply of 60 mcg/0.3 ml syringes of Aranesp, a medication used to treat anemia. The contract does not have a set-aside designation, indicating open competition. The ultimate completion date is June 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $6,731.22 by the Defense Logistics Agency Troop Support Medical to supply 500 microgram per milliliter syringes of ARANESP. The delivery order was issued against the Defense Logistics Agency's Prime Vendor program and requires performance at Amerisourcebergen's facility in Conshohocken, Pennsylvania between September 29 and October 2, 2023. No...
- This federal contract award, valued at $2,182.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication Aranesp 500 MCG/1 ML, with a completion date of May 8, 2025. This award is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $7,312.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ARANESP 500 MCG/1 ML SYRINGEML, a specialty medication, with a period of performance through April 3, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
- The Defense Logistics Agency awarded a $7,025 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ARANESP 300 MCG/0.6 ML SYRINGE. The place of performance is Conshohocken, Pennsylvania. The order is for the delivery of 0.6ml syringes of the anemia drug ARANESP to support DLA requirements. Amerisourcebergen will perform as the prime contractor under this short-term order issued from June 29-30, 2023. No subcontractors or set aside designations were indicated. This order...